THE DEGRADATION OF 5'-DEOXY-5-FLUOROURIDINE BY PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE IN NORMAL AND CANCER TISSUES

被引：19
|
作者：
CHOONG, YS [1 ]
LEE, SP [1 ]
机构：
[1] UNIV AUCKLAND,SCH MED,DEPT MED,AUCKLAND,NEW ZEALAND
来源：
CLINICA CHIMICA ACTA | 1985年 / 149卷 / 2-3期
关键词：
D O I：
10.1016/0009-8981(85)90331-6
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：175 / 183
页数：9
相关论文
共 50 条
  • [31] PHARMACOKINETIC-EFFECT RELATIONSHIPS OF 5'-DEOXY-5-FLUOROURIDINE IN HUMANS
    DEBRUIJN, EA
    VANOOSTEROM, AT
    TJADEN, UR
    REEUWIJK, HJEM
    PINEDO, HM
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1984, 6 (04) : 166 - 166
  • [32] SYNTHESIS AND GAMMA-RADIOLYSIS OF 2'-DEOXY-5-FLUOROURIDINE AND 5-FLUOROURIDINE DERIVATIVES
    KURODA, T
    HISAMURA, K
    MATSUKUMA, I
    NISHIKAWA, H
    MORIMOTO, M
    ASHIZAWA, T
    NAKAMIZO, N
    OTSUJI, Y
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 1992, 29 (05) : 1133 - 1142
  • [33] Thymidine phosphorylase expressed in macrophages enhances antitumor effect of 5′-deoxy-5-fluorouridine on human colorectal carcinoma cells
    Zhang, JM
    Mizoi, T
    Harada, N
    Shiiba, K
    Miyagawa, K
    Matsuno, S
    Sasaki, I
    ANTICANCER RESEARCH, 2003, 23 (1A) : 323 - 329
  • [34] 5'-deoxy-5-fluorouridine, medroxyprogestrone acetate and mitoxantrone hydrochloride for advanced or recurrent breast cancer
    Sato K.
    Hiraide H.
    Tamakuma S.
    Tabei T.
    Maruyama M.
    Touma M.
    Okamura H.
    Matsumoto F.
    Akao S.
    Ishikawa H.
    Yagi Y.
    Mochizuki H.
    Breast Cancer, 2001, 8 (1) : 58 - 62
  • [35] IDENTIFICATION OF 5-DEOXY-D-RIBITOL AS A MAJOR METABOLITE OF 5'-DEOXY-5-FLUOROURIDINE IN RATS
    ICHIHARA, S
    ICHIHARA, Y
    TOMISAWA, H
    FUKAZAWA, H
    TATEISHI, M
    DRUG METABOLISM AND DISPOSITION, 1985, 13 (04) : 520 - 521
  • [36] INTERACTION OF 5'-DEOXY-5-FLUOROURIDINE AND METHOTREXATE - A BASIS FOR REDUCED METHOTREXATE TOXICITY
    BOWEN, D
    ROBBINS, TJ
    WHITE, RM
    ARCHIVES OF TOXICOLOGY, 1989, 63 (05) : 401 - 405
  • [37] Inhibition of 5'-deoxy-5-fluorouridine phosphorolysis by acyclothymidine in tumor cell homogenates
    Hamada, A
    Nakano, M
    Shimidzu, S
    Hasegawa, T
    Kawaguchi, T
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1997, 20 (08) : 935 - 938
  • [38] Thymidine phosphorylase and dihydropyrimidine dehydrogenase levels in primary colorectal cancer show a relationship to clinical effects of 5′-deoxy-5-fluorouridine as adjuvant chemotherapy
    Nishimura, G
    Terada, I
    Kobayashi, T
    Ninomiya, I
    Kitagawa, H
    Fushida, S
    Fujimura, T
    Kayahara, M
    Shimizu, K
    Ohta, T
    Miwa, K
    ONCOLOGY REPORTS, 2002, 9 (03) : 479 - 482
  • [39] TUMOR INHIBITORY EFFECTS OF A NEW FLUOROURACIL DERIVATIVE - 5'-DEOXY-5-FLUOROURIDINE
    BOLLAG, W
    HARTMANN, HR
    EUROPEAN JOURNAL OF CANCER, 1980, 16 (04) : 427 - 432
  • [40] Preferential inhibition of bone metastases by 5′-deoxy-5-fluorouridine and capecitabine in a moose model of breast cancer
    Hiraga, T
    Hata, K
    Ikeda, F
    Kitagaki, J
    Ohuchi, K
    Tanaka, Y
    Yoneda, T
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (09) : 1579 - 1580
12345